Size Li
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Liver physiology and pathology 4
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Liver Disease and Transplantation 2
-
- Traditional Chinese Medicine Analysis 4
- Medical Research and Treatments 3
- Co-authors
- Xiaoqiang Xiang (4 shared papers)Hai‐Shu Lin (3 shared papers)Weimin Cai (3 shared papers)Yiqun Yu (2 shared papers)Xiaoke Li (14 shared papers)Jing Yuan (1 shared paper)Xiaolan Bian (1 shared paper)Bing Han (1 shared paper)
In The Last Decade
Size Li
26 papers receiving 264 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 43
- Drug Discovery 1
- Computational Theory and Mathematics 56
- Complementary and alternative medicine 26
- Hepatology 13
Countries citing papers authored by Size Li
This map shows the geographic impact of Size Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Size Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Size Li more than expected).
Fields of papers citing papers by Size Li
This network shows the impact of papers produced by Size Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Size Li. The network helps show where Size Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Size Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 59 | |
| 2 | 2020 | 41 | |
| 3 | 2019 | 28 | |
| 4 | 2023 | 27 | |
| 5 | 2020 | 15 | |
| 6 | 2023 | 10 | |
| 7 | 2024 | 9 | |
| 8 | 2025 | 9 | |
| 9 | 2024 | 8 | |
| 10 | 2024 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 2025 | 7 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2025 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 3 |
About Size Li
Size Li is a scholar working on Hepatology, Complementary and alternative medicine, Pharmacology, Computational Theory and Mathematics and Pharmacology, having authored 33 papers that have together received 272 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (4 papers), Traditional Chinese Medicine Analysis (4 papers), Medical Research and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Pharmacology (43 citations), Drug Discovery (1 citation), Computational Theory and Mathematics (56 citations), Complementary and alternative medicine (26 citations) and Hepatology (13 citations). Size Li has collaborated with scholars based in China, Singapore and Japan. Frequent co-authors include Xiaoqiang Xiang, Hai‐Shu Lin, Weimin Cai, Yiqun Yu, Xiaoke Li, Jing Yuan, Xiaolan Bian, Bing Han, Yan‐Ru Lou and Min Li. Their work appears in journals such as Frontiers in Pharmacology, The American Journal of Chinese Medicine, Journal of Ethnopharmacology, Antimicrobial Agents and Chemotherapy and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.